Targeting diseases with high unmet medical needs, social stigmas and limited treatment options.
We are dedicated to developing first-in-class and/or different-in-class treatment options across infectious diseases and central nervous system diseases, focusing on areas where patients experience high unmet medical needs, social stigmas and limited treatment options.
We are focused on accelerating the development of medicines to prevent, treat and cure a wide range of infectious diseases that profoundly affect patients around the world.
Central Nervous System Diseases
CNS diseases are among the most common in the world and have increased significantly over the last several decades. With few available therapies offering substantial treatment responses and remission, there is a significant need for new and innovative treatment options in this space – especially for patients with mental health illnesses who are often underserved and overlooked across the industry.